Evidence map›Paper›PMID 31490979›Full record

Trial reportPloS one2019

Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.

Jingwei Zhang, Zhenzhen Zhao, Hao Bai, Minjin Wang, Lin Jiao, Wu Peng, Tao Wu, Tangyuheng Liu, Hao Chen, Xingbo Song and 7 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Regulation of Gut Microflora byInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Frontiers in pharmacology · 2022
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Jingwei ZhangDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-7488-2929
Zhenzhen ZhaoDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Hao BaiDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Minjin WangDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Lin JiaoDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Wu PengDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Tao WuDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Tangyuheng LiuDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Hao ChenDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Xingbo SongDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Lijuan WuDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Xuejiao HuDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Qian WuDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Juan ZhouDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Jiajia SongDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Mengyuan LyvDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Binwu YingDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPregnane X receptor (PXR) regulates the expression of drug-metabolizing enzymes and transport enzymes. NF-κB not only plays a role in liver homeostasis and injury-healing processes by regulating inflammatory responses but may also regulate the transcription of PXR. Currently, genetic polymorphisms in PXR are associated with adverse drug effects. Because little is known about the association between NF-κB1 genetic polymorphisms and adverse drug reactions, we explored the association between PXR and NF-κB1 single nucleotide polymorphisms (SNPs) and susceptibility to anti-tuberculosis drug-induced liver injury (ATDILI). MATERIALS AND

methodsA total of 746 tuberculosis patients (118 with ATDILI and 628 without ATDILI) were prospectively enrolled at West China Hospital between December 2014 and April 2018. Nine selected SNPs (rs3814055, rs13059232, rs7643645 and rs3732360 in PXR and rs78872571, rs4647992, rs60371688, rs1598861 and rs3774959 in NF-κB1) were genotyped with a custom-designed 2x48-plex SNP Scan TM Kit. The frequencies of the alleles, genotypes and genetic models of the variants were compared between patients with or without ATDILI, while joint effect analysis of the SNP-SNP interactions was performed using multiplicative and additive models. The odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were calculated.

resultsThe T allele of rs3814055 in PXR was associated with a decreased risk for ATDILI (OR 0.61; 95% CI: 0.42-0.89, p = 0.0098). The T alleles of rs78872571 and rs4647992 in NF-κB1 were significantly associated with an increased risk for ATDILI (OR 1.91; 95% CI: 1.06-3.43, p = 0.028 and OR 1.81; 1.06-3.10, p = 0.029, respectively). The allele, genotype and genetic model frequencies were similar in the two groups for the other six SNPs (all P>0.05). There were no multiplicative or additive interactions between the SNPs.

conclusionOur study is the first to reveal that rs3814055 variants in PXR and rs78872571 and rs4647992 variants in NF-κB1 are associated with susceptibility to ATDILI caused by first-line anti-tuberculosis combination treatment in the Han Chinese population.

Indexed as

Polymorphism, Single NucleotideAdultAllelesAntitubercular AgentsCase-Control StudiesChemical and Drug Induced Liver InjuryFemaleGenetic Predisposition to DiseaseHaplotypesHumansMaleNF-kappa B p50 SubunitPregnane X ReceptorProspective StudiesAntitubercular AgentsNF-kappa B p50 SubunitNFKB1 protein, humanPregnane X Receptor

Identifiers

PMID31490979
PMCPMC6730870
OpenAlexW2971934062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.